Semaglutide_Dosage, benefits & legal status
Also known as Ozempic, Wegovy, Rybelsus, GLP-1 SM, GLP-1 S, GLP-1 (S), sema, EZP-1P, GLP-1 SG, EP-1 S
The drug in Ozempic and Wegovy: a weekly shot that curbs hunger for steady weight loss.
Common vial size is what vendors typically sell, not a recommendation. Enter your own vial in the calculator.
What is Semaglutide?
Plain language first. The technical label stays, but it never stands alone.Overview
It flips on your 'I'm full' signal, so you feel satisfied sooner, eat less, and your blood sugar steadies. It is the active drug in Ozempic and Wegovy.
Semaglutide is a GLP-1 receptor agonist, a lab-made copy of a natural gut hormone your body releases after eating.
What it's used for
People use it to lose weight and steady their blood sugar. It calms appetite and cravings so you feel full sooner and eat less without white-knuckling it.
How does Semaglutide work?
What it does in the body, and where.Semaglutide copies a single gut hormone, GLP-1. That one target is enough to change how hungry you feel, how fast your stomach empties, and how your body handles sugar after a meal.
- 01It docks at the GLP-1 receptorThe same receptor your own gut hormone uses after you eat, so your body reads it as an ordinary fullness signal.
- 02Your stomach empties more slowlyFood sits longer, so you stay full for longer. This is also where most of the nausea comes from.
- 03Appetite signalling in the brain quiets downCravings and food noise drop, which is what most people notice first and miss most when they stop.
Acts on one receptor.
What else is it used for?
Each group carries its own evidence level.Approved means regulators have cleared it for that purpose. Investigational means it is in trials. Early research means it is being studied and is not established.
Weight loss
FDA-approved- Human trialIn a 68-week trial, average weight loss was 14.9% of body weight versus 2.4% on a dummy injection.
- Human trial86.4% of people lost at least 5% of their body weight, against 31.5% on placebo.
- Human trial34.8% lost at least a fifth of their body weight, against 2.0% on placebo.
- Human trialIn the follow-up, people who had lost 17.3% regained 11.6 percentage points within a year of stopping, leaving a net loss of 5.6%. Most of the weight comes back if you stop.
Diabetes and heart health
FDA-approved- Human trialIn people who already had type 2 diabetes, average weight loss was 9.6% versus 3.4% on placebo, so it works but somewhat less well.
- RegulatoryApproved as Ozempic in 2017 for type 2 diabetes and as Wegovy in 2021 for weight management.
Trial weight-loss figures are often quoted without the follow-up: people regained most of the weight within a year of stopping.
The published record
6,371
Records indexed for Semaglutide400 papers and 100 trials indexed in detail.
261 in humans, 127 of them original studies.
754 registered trials, 18 with posted results among the 100 indexed.
FDA: Named as an unapproved new drug.
Counted from Europe PMC indexing, not read by a person. Human means indexed under humans, which includes reviews and work on human cells. Original studies exclude reviews and lab work on human cells.Last updated 11 September 2026.

At a glance
Four things to know about Semaglutide
Evidence
FDA-approved
Category
Weight loss and metabolic
Common vial
5 mg
Half-life
About 1 week
How much, and do you cycle it?
The range, and whether you take breaks.0.25 up to 2.4 mg per week (start low, increase slowly), weekly. Not cycledHuman study
Taken continuously, with the dose stepped up rather than paused. In the STEP 1 extension people regained about two thirds of the weight they had lost within a year of stopping. The question is whether to stay on it, not when to take a break.
How long does it stay in the body?
The half-life, and where the figure comes from.About 1 weekFDA label
The label states approximately 1 week, and that semaglutide is present in the circulation for about 5 weeks after the last dose.
Source: Ozempic (semaglutide) US prescribing information, section 12.3. DailyMed setid adec4fd2-6858-4c99-91d4-531f5f2a2d79
You can compare this against the whole library to see where it sits.
How do I dose and price it?
Enter your vial and your dose. Pick a mix. We show the draw and the cost.The vial holds a fixed amount of drug. Adding more water does not make more drug, it just spreads it thinner, so you draw a bigger number on the syringe for the same dose.
Choose your mix
Measuring the water1 mL = one full 100-unit syringe.
Your draw
10 / 100 unitsSemaglutide starts at $10.00 across 45 vendors, typically $3.20 – $21.40 per mg.
100 listings, last read Sep 5, 2026. Shipping and card fees are not included.
How do you store it?
Before mixing, and after.Fridge before first use. Room temperature is fine once in use.
Sealed pens live in the fridge. Once you start a pen it can stay at room temperature for the in-use window on the label (often about 4 to 6 weeks depending on the product). Keep it out of light, do not freeze it, and toss it if it has been frozen or left hot.
What are the side effects and cautions?
Known cautions and warnings for this compound.Vials sold as "GLP-1 SM" or "GLP-1 (S)" are semaglutide. GLP-1 on its own is a hormone and a whole class of drugs, so the bare term does not identify what is in a vial. Check the label for semaglutide.
Who should avoid it
- A personal or family history of medullary thyroid cancer, or the genetic condition MEN 2
- Pregnancy, or trying to become pregnant
- A history of pancreatitis, which needs a conversation with your doctor first
- Severe stomach-emptying problems (gastroparesis)
Stop and get help
- Severe stomach pain that spreads to your back, which can signal pancreas inflammation
- A lump or swelling in your neck, hoarseness, or trouble swallowing
- Vomiting badly enough that you cannot keep fluids down
- Sudden changes in your vision
- Signs of an allergic reaction such as face or throat swelling or trouble breathing
Common effects
- Nausea, which is the most common effect and usually worst in the first weeks and after each dose increase
- Diarrhea, constipation, and vomiting
- Tiredness, which real-world users report far more often than trial write-ups suggest
- Burping and reflux
- Injection-site redness
What regulators say
- FDA: Warning letter to Royal Peptides LLC, MARCS-CMS 734884, August 24, 2026: unapproved new drugs, misbrandedNamed as an unapproved new drug
The vendor's product, not the approved Ozempic or Wegovy
Checked 11 September 2026
Where this page says nothing is established, that means nobody has studied it, not that a compound is safe.
Is Semaglutide approved?
And where the numbers on this page come from.Yes. Semaglutide is FDA approved and available on prescription in the United States.
- Approval statusFDA-approved
- RouteUnder the skin (also comes as a pill)
- CheckedAugust 2026
What has happened recently
In January 2026 the FDA asked that the warning about suicidal thoughts and behaviour be removed from the obesity versions of this drug family after a review found no increased risk. Labels were updated in February 2026.
You can compare this against the whole library, or read how to check a seller.
- DoseFrom the drug label. The manufacturer tested this range and a regulator reviewed it.
- Vial sizeFrom what vendors typically list; not a recommendation.
- Sources
- Reviewed14 August 2026
What else is like Semaglutide?
Others in GLP-1 agonists, side by side.If you're weighing Semaglutide, it's worth reading Tirzepatide, Retatrutide, and Liraglutide in the same class.
The drug in Ozempic and Wegovy: a weekly shot that curbs hunger for steady weight loss.
- Dose
- 0.25 up to 2.4 mg per week (start low, increase slowly)
- How often
- Weekly
The drug in Mounjaro and Zepbound: a weekly shot for major weight loss and blood sugar.
- Dose
- 2.5 up to 15 mg per week (start low, increase slowly)
- How often
- Weekly
An experimental weekly shot with some of the biggest weight-loss numbers yet in trials.
- Dose
- 1 up to 12 mg per dose (start low, increase slowly)
- How often
- Weekly
A daily version of the Ozempic-style shot for weight loss and blood sugar.
- Dose
- 0.6 up to 3 mg per day (start low, increase slowly)
- How often
- Daily
Guides for this compound
- How to Reconstitute a Peptide
Mix peptide powder with bacteriostatic water, step by step.
- How to Read an Insulin Syringe
Read the units, convert to millilitres, and draw the exact dose.
- mcg vs mg: The Peptide Dosing Mistake to Avoid
Your vial says mg and your protocol says mcg. Here is the conversion and how to check it.
- Why Does My Peptide Injection Itch or Welt
Injection-site irritation, a histamine reaction, or a true allergy, and how to tell them apart.
- Semaglutide vs Tirzepatide vs Retatrutide
One receptor, two, or three. Mechanism, trial weight loss, side effects, and real cost.
Sources
- FDA, approval for MASH liver disease(2025)FDA accelerated approval for MASH liver disease in adults with moderate to advanced scarring.
- FDA, removal of the suicidal-ideation warning (Jan 2026)(2026)FDA asked for the suicidal-ideation warning to be removed after a review found no increased risk.
- NIH PMC, semaglutide and alcohol use disorder trial(2025)Randomised trial reporting reduced alcohol craving and fewer heavy-drinking days.
- STEP 1 trial, New England Journal of Medicine, 2021
- STEP 1 analysis, PubMed Central
Last reviewed 14 August 2026
Beyond these, 500 records are indexed. Browse the records
